Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

AGM Statement

29 Sep 2010 07:00

RNS Number : 4602T
Imaginatik PLC
29 September 2010
Β 

ο»Ώ

Β 29 September 2010

Imaginatik plc

("Imaginatik" or the "Company")

Β 

AGM Statement

Contract Win and Management Appointments

Β 

At the Company's Annual General Meeting to be held later today, Matthew Cooper, Executive Chairman of Imaginatik plc (AIM: IMTK.L), a leading provider of idea management software and innovation consultancy, will make the following statement:

Β 

"We continue to make steady progress towards achieving our strategic goals. A new management team is now largely in place and has been further strengthened by the two recent appointments referred to below.

Β 

"As stated in the announcement dated 18 August 2010, we believe that it will take time to rebuild the Company's sales pipeline. However, the recently announced contract wins and a further win with the U.S. Government announced today are evidence of a growing momentum.

Β 

"While the re-organisation of the business earlier this year will inevitably have an impact on results for the first half of the year, we expect to see a return to more normal levels of sales in the second half.

Β 

"The calibre of people joining our team and the high profile customers with whom we continue to work give us confidence in the future of Imaginatik."

Β 

The Company also announces today a contract win and two senior management team appointments.

Β 

Contract to supply innovation solutions to the United States Government, General Services Administration

Β 

Imaginatik has been selected as a strategic innovation solutions provider by QinetiQ North America, Inc. in support of the United States Government, General Services Administration (the "GSA"). QinetiQ North America, one of the world's leading defence technology and security companies, has issued Imaginatik a six month Subcontract Agreement worth over $400,000, with one six month option period, to assist in enabling Business Transformation and Collaboration at the GSA. Under this Agreement, Imaginatik will use its Idea Central Collaboration Platform to assist GSA in identifying innovation strategies to enhance business practices. It includes licenses for GSA's 15,000 associates, facilitation and programme management support, and various training initiatives to foster collaboration at GSA.

Β 

Senior Appointments

Β 

Imaginatik is also pleased to announce it has made two recent senior appointments to strengthen the Company's sales and product development capabilities. Neither appointment is a Board position.

Β 

Kevin Grygiel has been appointed Global Vice-President of Sales. Based in Boston, Kevin will lead the sales organisation, reporting to Luis Solis the Vice-President of Business Development. Kevin has more than 20 years in software sales, with the last eight years at SiteScape Inc. a collaboration and social media software business. This appointment affirms the Company's commitment to bringing in high calibre sales executives with relevant expertise capable of growing the business.

Β 

Robin Spencer, previously Senior Research Fellow, Idea Management & Innovation at Pfizer Inc., has joined Imaginatik as Director of Research. Rob will work within the Product Development team in building out all future product enhancements and will continue Imaginatik's tradition of leading edge empirical research within our field of innovation and collaborative problem solving.

Β 

For further information please contact:

Β 

Imaginatik plc

Tel: 020 7917 2975

Matthew Cooper, Chairman / Shawn Taylor, CFO

Arbuthnot Securities Limited

Tel: 020 7012 2000

Tom Griffiths

Threadneedle Communications

Tel: 020 7653 9850

Caroline Evans-Jones / Hilary Millar

Β 

Β 

About Imaginatik

Β 

Imaginatik provides Innovation and idea management solutions to companies such as The Chubb Group of Insurance Companies, Boeing, Pfizer, Xerox, Goodyear and Cargill. Few companies possess the internal capability to consistently generate fresh ideas, identify those worth pursuing and reliably transform them into real, value-enhancing assets. This is Imaginatik's area of expertise.

Β 

Imaginatik provides customers with strategic consulting, the award-winning Idea Central technology solution and an experienced, results-oriented innovation consulting team.

Β 

Imaginatik is a public company whose shares are traded on the AIM market of the London Stock Exchange (LSE:IMTK.L) and a World Economic Forum Technology Pioneer with offices in Boston, MA, and London. In 2009, Imaginatik was named as one of the 500 fastest growing technology companies in the EMEA region by Deloitte.

Β 

For more information visit www.imaginatik.com.

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
AGMDMGZLKRGGGZM
Date   Source Headline
19th Dec 20083:16 pmRNSDirector/PDMR Shareholding
18th Dec 20089:45 amRNSDirector/PDMR Shareholding
17th Dec 20087:00 amRNSShare Option Schemes
1st Dec 20087:00 amRNSDirector's Disclosure Update
19th Nov 200812:39 pmRNSDirectors Dealing
13th Nov 20087:00 amRNSInterim Results
14th Oct 20087:00 amRNSTrading Statement
2nd Oct 20087:00 amRNSContract Win
30th Sep 20084:30 pmRNSTotal Voting Rights
24th Sep 20087:00 amRNSDirector/PDMR Shareholding
15th Sep 20087:00 amRNSContract Win
3rd Sep 20087:00 amRNSIssue of Equity
21st Aug 20087:00 amRNSContract Win
28th Jul 20089:27 amRNSNon-Executive Retirement
10th Jul 200810:20 amRNSResult of AGM
10th Jul 20087:00 amRNSAGM Statement
24th Jun 20087:00 amRNSDirector/PDMR Shareholding
18th Jun 200810:05 amRNSAnnual Report and Accounts
13th Jun 200812:16 pmRNSDirector/PDMR Shareholding
11th Jun 20087:00 amRNSFinal Results
1st Apr 200811:52 amRNSDirector Dealings
31st Mar 20084:30 pmRNSTotal Voting Rights
17th Mar 20082:57 pmRNSShare Subscription - Update
10th Mar 20082:23 pmRNSShare Subscription
10th Mar 20089:30 amRNSHolding(s) in Company
28th Feb 200810:01 amRNSPfizer Update
13th Feb 20089:40 amRNSTrading Statement
22nd Jan 20089:30 amRNSWorld Economic Forum
11th Jan 200810:13 amRNSMajor Contract Wins
30th Nov 20072:41 pmRNSWEF Technology Pioneer
14th Nov 20072:12 pmRNSInterim Results
16th Aug 200711:05 amRNSAgreement With IBM
14th Aug 20074:55 pmRNSAIM Rule 26 Information
27th Jul 200710:46 amRNSAGM Statement
27th Jul 20077:01 amRNSAGM Statement
11th Jul 200712:00 pmBUSGlobal Competition Forces Innovation and Collaboration Acceleration
29th Jun 20073:33 pmRNSAnnual Report and Accounts
13th Jun 200711:50 amRNSResult of EGM
12th Jun 20077:02 amRNSFinal Results
4th Jun 20077:02 amRNSUK & European Contract Wins
1st Jun 200710:29 amRNSNotice of Results
18th May 200710:05 amRNSNotice of EGM
23rd Apr 20072:38 pmBUSImaginatik Wins a Queens Award for Enterprise
23rd Apr 200711:02 amRNSWins A Queens Award
19th Apr 200710:59 amRNSDirector/PDMR Shareholding
21st Mar 20077:04 amRNSSenior Management Appointment
21st Mar 20077:01 amBUSImaginatik Appoints President, Americas and New CMO to Accommodate Growth
16th Mar 200711:45 amRNSTrading Statement
9th Feb 200711:30 amBUSImaginatik Appoints Managing Director in United Kingdom
9th Feb 20077:00 amRNSAppointment of UK MD

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.